SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-014013
Filing Date
2023-05-11
Accepted
2023-05-11 19:57:22
Documents
2
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1454
2 poa_calder.htm EX-24 6679
  Complete submission text file 0001437749-23-014013.txt   9673
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 324 S. HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address
Calder Douglas W (Reporting) CIK: 0001510445 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36913 | Film No.: 23912772